Actionable news
All posts from Actionable news
Actionable news in BIIB: Biogen Idec Inc.,

Is Biogen's Rough Ride Over?

Year to date, shares of Biogen (BIIB) are up about 2%, and would have been down more if not for a 40% move off the bottom.

Investors in Biogen have had a rough ride. The stock started the year down, as the shares were still feeling the side effects of a big guidance cut last summer. Management slashed sales guidance for its multiple scoliosis therapy Tecfidera last year. Sales of Tecfidera peaked in the second quarter of 2015. Sales growth dropped from 26% to 7%...